Free tool
Oncology stocks
We cover 86 companies grouped under the Oncology theme. The median market value in the group is $757.27M. Across the group, the median move over the past trading day is −0.54%. 65% of the 83 with a 200-day average trade above it. Price change over the past year runs from −24.0% to +198.0% across the middle 80 percent of the group, with a median of +35.1%. Across the group, 3 companies currently carry a tier A volume signal.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
86 of 319 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return | Next report |
|---|---|---|---|---|---|
| 6MK.DE | Merck & Co., Inc. | $379.64B | Mega cap | +91.49% | Oct 29, 2026 |
| MRK | Merck & Co., Inc. | $377.72B | Mega cap | +86.85% | Oct 29, 2026 |
| AZN.L | AstraZeneca PLC | $264.05B | Mega cap | +5.65% | Oct 30, 2026 |
| AZN | AstraZeneca PLC | $263.12B | Mega cap | +5.09% | Oct 30, 2026 |
| BMY | Bristol-Myers Squibb Company | $138.03B | Large cap | +47.01% | Oct 29, 2026 |
| 4519.T | Chugai Pharmaceutical Co., Ltd. | $71.92B | Large cap | +9.21% | Oct 27, 2026 |
| RVMD | Revolution Medicines, Inc. | $46.18B | Large cap | +466.35% | Nov 4, 2026 |
| ONC | BeOne Medicines AG | $42.58B | Large cap | +25.21% | Nov 5, 2026 |
| 4568.T | Daiichi Sankyo Company, Limited | $32.82B | Large cap | −17.94% | Oct 30, 2026 |
| BNTX | BioNTech SE | $28.28B | Large cap | +9.27% | Nov 3, 2026 |
| INCY | Incyte Corporation | $25.97B | Large cap | +51.01% | Oct 27, 2026 |
| GMAB | Genmab A/S | $21.42B | Large cap | +36.20% | Nov 5, 2026 |
| GE9.DE | Genmab A/S | $20.65B | Large cap | −11.12% | Nov 5, 2026 |
| EXEL | Exelixis, Inc. | $14.05B | Large cap | +45.68% | Oct 27, 2026 |
| SMMT | Summit Therapeutics Inc. | $11.35B | Large cap | −42.63% | Oct 19, 2026 |
| GXE.DE | Lakefront Biotherapeutics NV | $1.93B | Small cap | −44.50% | Nov 12, 2026 |
| IMCR | Immunocore Holdings plc | $1.93B | Small cap | +13.69% | Nov 5, 2026 |
| DMRA | Damora Therapeutics, Inc. | $1.89B | Small cap | +804.46% | Nov 5, 2026 |
| VIR | Vir Biotechnology, Inc. | $1.87B | Small cap | +111.85% | Nov 4, 2026 |
| INBX | Inhibrx Biosciences, Inc. | $1.81B | Small cap | +357.45% | Nov 13, 2026 |
| SNDX | Syndax Pharmaceuticals, Inc. | $1.77B | Small cap | +23.55% | Nov 2, 2026 |
| BCAX | Bicara Therapeutics Inc. | $1.64B | Small cap | +105.74% | Nov 10, 2026 |
| AVBP | ArriVent BioPharma, Inc. | $1.54B | Small cap | +62.10% | Nov 16, 2026 |
| REPL | Replimune Group, Inc. | $1.50B | Small cap | +187.16% | Nov 5, 2026 |
| CGEM | Cullinan Therapeutics, Inc. | $1.48B | Small cap | +188.15% | Nov 5, 2026 |
| AKTS | Aktis Oncology, Inc. | $1.47B | Small cap | +18.35% | Nov 12, 2026 |
| ORIC | ORIC Pharmaceuticals, Inc. | $1.44B | Small cap | +35.58% | Nov 12, 2026 |
| IMTX | Immatics N.V. | $1.41B | Small cap | +74.63% | Nov 17, 2026 |
| DRTS | Alpha Tau Medical Ltd. | $1.38B | Small cap | +343.92% | Nov 19, 2026 |
| GLUE | Monte Rosa Therapeutics, Inc. | $1.23B | Small cap | +207.92% | Nov 5, 2026 |
| CRVS | Corvus Pharmaceuticals, Inc. | $1.22B | Small cap | +167.82% | Nov 3, 2026 |
| KURA | Kura Oncology, Inc. | $1.16B | Small cap | +66.16% | Nov 3, 2026 |
| JANX | Janux Therapeutics, Inc. | $1.15B | Small cap | −19.10% | Nov 5, 2026 |
| 2160.T | GNI Group Ltd. | $1.14B | Small cap | +8.36% | Nov 13, 2026 |
| CADL | Candel Therapeutics, Inc. | $1.02B | Small cap | +124.70% | Nov 12, 2026 |
| GERN | Geron Corporation | $995.83M | Small cap | +8.51% | Nov 4, 2026 |
| EUZ.DE | Eckert & Ziegler SE | $952.11M | Small cap | −24.60% | Nov 12, 2026 |
| OLMA | Olema Pharmaceuticals, Inc. | $949.35M | Small cap | +89.02% | Nov 9, 2026 |
| 4587.T | PeptiDream Inc. | $891.51M | Small cap | −27.31% | Nov 11, 2026 |
| RIGL | Rigel Pharmaceuticals, Inc. | $864.97M | Small cap | +16.99% | Nov 3, 2026 |
| NVCT | Nuvectis Pharma, Inc. | $816.10M | Small cap | +275.94% | Nov 3, 2026 |
| AURA | Aura Biosciences, Inc. | $801.64M | Small cap | +20.03% | Nov 12, 2026 |
| MNPR | Monopar Therapeutics Inc. | $763.31M | Small cap | +226.69% | Nov 12, 2026 |
| BBOT | BridgeBio Oncology Therapeutics, Inc. | $751.23M | Small cap | −0.43% | Nov 11, 2026 |
| CTMX | CytomX Therapeutics, Inc. | $723.43M | Small cap | +60.39% | Nov 5, 2026 |
| GUD.TO | Knight Therapeutics Inc. | $690.78M | Small cap | +50.39% | Nov 5, 2026 |
| EIKN | Eikon Therapeutics, Inc. | $679.77M | Small cap | −20.13% | Nov 12, 2026 |
| SGMT | Sagimet Biosciences Inc. | $675.04M | Small cap | +39.59% | Nov 12, 2026 |
| VSTM | Verastem, Inc. | $641.19M | Small cap | −20.45% | Nov 3, 2026 |
| ARVN | Arvinas, Inc. | $609.40M | Small cap | +15.35% | Nov 4, 2026 |
| DCTH | Delcath Systems, Inc. | $569.06M | Small cap | +49.91% | Nov 3, 2026 |
| PRLD | Prelude Therapeutics Incorporated | $522.47M | Small cap | +412.50% | Nov 11, 2026 |
| CCCC | C4 Therapeutics, Inc. | $521.63M | Small cap | +64.34% | Nov 5, 2026 |
| TOI | Starling Oncology Inc | $512.91M | Small cap | +79.19% | Nov 9, 2026 |
| RLMD | Relmada Therapeutics, Inc. | $485.35M | Small cap | +579.10% | Nov 12, 2026 |
| PBYI | Puma Biotechnology, Inc. | $472.84M | Small cap | +79.61% | Nov 5, 2026 |
| CMPX | Compass Therapeutics, Inc. | $437.61M | Small cap | −25.91% | Nov 5, 2026 |
| FRX.TO | Fennec Pharmaceuticals Inc. | $429.52M | Small cap | +36.00% | Nov 12, 2026 |
| FENC | Fennec Pharmaceuticals Inc. | $426.77M | Small cap | +34.62% | Nov 12, 2026 |
| PRTC.L | PureTech Health plc | $398.28M | Small cap | −4.27% | Aug 27, 2026 |
| FHTX | Foghorn Therapeutics Inc. | $397.29M | Small cap | +23.66% | Nov 5, 2026 |
| AGEN | Agenus Inc. | $371.33M | Small cap | +81.72% | Nov 5, 2026 |
| ZNTL | Zentalis Pharmaceuticals, Inc. | $368.27M | Small cap | +113.74% | Nov 10, 2026 |
| CATX | Perspective Therapeutics, Inc. | $360.72M | Small cap | −12.47% | Nov 9, 2026 |
| IMRX | Immuneering Corporation | $333.19M | Small cap | −0.77% | Nov 11, 2026 |
| BCYC | Bicycle Therapeutics plc | $304.03M | Small cap | −37.79% | Oct 29, 2026 |
| PYXS | Pyxis Oncology, Inc. | $278.58M | Small cap | +145.59% | Nov 2, 2026 |
| WHWK | Whitehawk Therapeutics, Inc. | $275.92M | Small cap | +167.40% | Nov 5, 2026 |
| ALXO | ALX Oncology Holdings Inc. | $273.79M | Small cap | +65.00% | Nov 6, 2026 |
| CGEN | Compugen Ltd. | $271.86M | Small cap | +93.20% | Nov 9, 2026 |
| GLSI | Greenwich LifeSciences, Inc. | $267.58M | Small cap | +56.21% | Nov 12, 2026 |
| MGNX | MacroGenics, Inc. Common Stock | $257.35M | Small cap | +134.88% | Nov 12, 2026 |
| IPHA | Innate Pharma S.A. | $253.56M | Small cap | +2.86% | Sep 17, 2026 |
| IDD.DE | Innate Pharma S.A. | $243.27M | Small cap | −2.52% | Sep 17, 2026 |
| IPH.PA | Innate Pharma S.A. | $240.15M | Small cap | +1.19% | Sep 17, 2026 |
| TARA | Protara Therapeutics, Inc. | $231.06M | Small cap | +21.05% | Nov 10, 2026 |
| CHRS | Coherus Oncology, Inc. | $224.03M | Small cap | +27.19% | Nov 5, 2026 |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | $218.56M | Small cap | +7.93% | Nov 16, 2026 |
| BINV.ST | BioInvent International AB (publ) | $162.35M | Small cap | −23.46% | Aug 27, 2026 |
| HURA | TuHURA Biosciences, Inc. | $135.74M | Small cap | −26.55% | Nov 13, 2026 |
| ADCT | ADC Therapeutics SA | $134.05M | Small cap | −67.39% | Nov 10, 2026 |
| BDTX | Black Diamond Therapeutics, Inc. | $130.42M | Small cap | −20.91% | Nov 5, 2026 |
| ANIX | Anixa Biosciences, Inc. | $122.65M | Small cap | +22.20% | Sep 9, 2026 |
| NTHI | NeOnc Technologies Holdings, Inc. | $122.16M | Small cap | −29.30% | Nov 12, 2026 |
| ONCY | Oncolytics Biotech Inc. | $109.10M | Small cap | −19.28% | Nov 16, 2026 |
| HBP.TO | Helix BioPharma Corp. | $106.76M | Small cap | +46.97% | Oct 29, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.